跳至主要内容
临床试验/ACTRN12614000946617
ACTRN12614000946617已完成2 期

Evaluation of kunzea oil for the management of toenail onychomycosis with amorolfine lacquer, a pilot randomised, controlled trial.

niversity of Tasmania0 个研究点目标入组 130 人开始时间: 2014年9月4日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Entry criteria required a clinical diagnosis of onychomycosis (based on clinical manifestations and positive mycology [mycological culture]) involving less than or equal to 20% of the area of one of the great toenails and a minimum age of 18

排除标准

  • The main exclusion criteria were other nail conditions (psoriasis, bacterial infections, contact dermatitis, nail bed tumours, yellow nail syndrome, traumatic onychodystrophies, lichen planus, pachonychia congenita and idiopathic onycholysis ) confounding onychomycosis assessment, pregnancy, breast-feeding, and a known history of allergy to essential oils. All patients had a 6-week washout period for systemic antifungal therapy and 4 weeks for topical antifungal treatment prior to receiving the study drugs

研究者

发起方
niversity of Tasmania

相似试验